Compound Information | SONAR Target prediction | Name: | EPIANDROSTANEDIOL | Unique Identifier: | SPE00107093 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C19H32O2 | Molecular Weight: | 261.21 g/mol | X log p: | -0.0960000000000001 (online calculus) | Lipinksi Failures | 0 | TPSA | 0 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 2 | Rotatable Bond Count: | 0 | Canonical Smiles: | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O | Source: | ex numerous mammalian tissues | Therapeutics: | regulation of puberty in females | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Drug_type: | Experimental | Drugbank_id: | EXPT00530 | Logp: | 3.73 | Drug_category: | Sex Hormone-Binding Globulin inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
BCK1 |
Replicates: |
2 |
Raw OD Value: r im |
0.4801±0.00282843 |
Normalized OD Score: sc h |
0.7213±0.000999504 |
Z-Score: |
-5.4479±0.115872 |
p-Value: |
0.0000000562834 |
Z-Factor: |
0.632361 |
Fitness Defect: |
16.6929 |
Bioactivity Statement: |
Active |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 2|G7 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 24.50 Celcius | Date: | 2006-03-24 YYYY-MM-DD | Plate CH Control (+): | 0.038675±0.00123 | Plate DMSO Control (-): | 0.6602250000000001±0.02150 | Plate Z-Factor: | 0.9014 |
| png ps pdf |
6573956 |
(1R,2R,4S,5S)-4,5-dimethyl-2-[(1R,2R,4R)-1,7,7-trimethylnorbornan-2-yl]cyclohexan-1-ol |
6574226 |
(1R,2S,6R)-2-methyl-6-[(1R,2R,4R,6S)-5,5,6-trimethylnorbornan-2-yl]cyclohexan-1-ol |
6576599 |
(3S,5R,8S,9S,10R,13S,14R,17S)-17-(1-hydroxyethyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetra decahydro-1H-cyclopenta[a]phenanthren-3-ol |
6577151 |
n/a |
6577979 |
(1S,2S,4S,6S)-2,4-dimethyl-6-[(1R,2S,4S)-norbornan-2-yl]cyclohexan-1-ol |
6579032 |
n/a |
active | Cluster 12674 | Additional Members: 6 | Rows returned: 4 | |
|